Image 1 (IMAGE)

Nanyang Technological University

Image 1

Caption

A team of scientists led by NTU Singapore has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options and is often associated with poor outcomes.

Credit

NTU Singapore

Usage Restrictions

Use with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.